CClinicalTrials.gg
CompletedNCT00890331Updated Jan 8, 2016

Prevention of Self-care Deterioration in Early Adolescents With Diabetes

A Phase 1 interventional study of TeamWork CS Sessions and Diabetes Education in Type 1 Diabetes, sponsored by Virginia Commonwealth University. Completed at 2 sites in United States. Open to participants aged 11 Years to 14 Years. Per ClinicalTrials.gov, last updated 2016-01-08.

Sponsored by Virginia Commonwealth University · Phase 1, Interventional, and Prevention

Phase
Phase 1
Study type
Interventional
Enrollment
285
Allocation
Randomized
Ages
11 Years to 14 Years
Sex
All
01

Study summary

Establish the efficacy of a brief, clinic-based prevention program of teamwork coping skills for youth and their parents during in a high risk period of early adolescence (11-14 yrs) when parental involvement and self-care deterioration occurs.

Read the detailed description

Promotion of optimal disease care and metabolic control in youth with Type 1 diabetes is an important goal of disease management during early adolescence. Typically youth assume increasing responsibility for these goals along with parental involvement and guidance. However, as youth progress through adolescence, parents often become less involved in diabetes management and poorer self-care and metabolic control often results.

The goal of the prevention program is to encourage parents to remain involved in their child's diabetes care throughout adolescence and to provide tools to help make that involvement a positive experience. To minimize parent/child conflict that may accompany sustained parental involvement, sessions of the active treatment review the following coping skills: communication, problem solving, conflict resolution, attitude and behavior change. Meetings occur in-clinic in conjunction with four consecutive medical appointments.

The educational comparison group also meets with study researchers for in-clinic sessions that occur in conjunction with four consecutive medical appointments. Families discuss a variety of helpful educational diabetes topics and resources.

The overarching project goal is to demonstrate the efficacy of a brief, prevention focused coping skills program for youth with type 1 diabetes and their parents with the ultimate goal of translation into routine pediatric care.

02

Conditions studied

  • Type 1 Diabetes
03

In context

Diabetes Mellitus, Type 1

3,521 studies on the registry are indexed under Diabetes Mellitus, Type 1; 576 are open to participants now.

This study's enrollment of 285 is above the median of 40 across 2,648 interventional studies indexed under Diabetes Mellitus, Type 1.

Browse Diabetes Mellitus, Type 1 studies →

Lead sponsor

Virginia Commonwealth University is the lead sponsor of 641 studies on the registry; 82 are open to participants now.

Of its 88 completed or terminated interventional studies of FDA-regulated products, 62 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Seen for Diabetes care at Virginia Commonwealth University or Children's National Medical Center
  • Child ages 11-14
  • Type 1 Diabetes
  • Fluent in English
  • Ability to comprehend and complete questionnaires independently

Exclusion criteria

Exclusion Criteria:

  • The presence of any other major disease
  • The presence of any severe diabetic complications which could impair test performance
  • Use of any medication that affects the CNS other than insulin
  • Inability to speak/comprehend and read English
  • Placement in special classes for the mentally disabled
05

Study design

Phase
Phase 1
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
285 participants (actual)

Study arms

  • Active comparator
    Diabetes Education

    Behavioral: Diabetes Education

  • Experimental
    TeamWork CS Sessions

    Behavioral: TeamWork CS Sessions

Interventions

  • BehavioralTeamWork CS Sessions

    The intervention focuses on an authoritative parenting approach that emphasizes continued parental involvement in daily disease care. Dyadic coping skills of communication, problem solving, conflict resolution, along with attitude and behavior change are highlighted. Families meet with a study interventionist in conjunction with four consecutive medical appointments.

  • BehavioralDiabetes Education

    Diabetes Education The education comparison group meets with an educational interventionist in conjunction with four consecutive medical appointments. This group focuses on diabetes educational and resource support for parents and their youth with type 1 diabetes.

06

What researchers measure

Primary outcomes

  1. Parental involvement and Disease care behaviors

    Time frame: Baseline, (optional 3, 6, and 9 months) 12, 15, 18 and 24 months

Secondary outcomes

  1. Glycohemoglobin levels, Adverse effects and Blood glucose variability

    Time frame: Baseline, 3, 6, 9, 12, 15, 18, and 24 months

07

Study locations

2 sites
  • Children's National Medical Center
    Washington, District of Columbia 20010, United States
  • Virginia Commonwealth University
    Richmond, Virginia 23284, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00890331
Lead sponsor
Virginia Commonwealth University
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Children's National Research Institute
Responsible party
Sponsor
First posted
Apr 29, 2009
Start date
Apr 2007
Primary completion
Mar 2014
Completion
Mar 2014
Last update
Jan 8, 2016

Study contacts

Clarissa S Holmes, Ph.D.
principal investigator · Virginia Commonwealth University
Randi Streisand, Ph.D.
principal investigator · Children's National Research Institute
Rusan Chen, Ph.D.
study director · Georgetown University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion